145 related articles for article (PubMed ID: 29169619)
21. Immunohistochemical expression of COX-2, mPGES and EP2 receptor in normal and reactive canine bone and in canine osteosarcoma.
Millanta F; Asproni P; Cancedda S; Vignoli M; Bacci B; Poli A
J Comp Pathol; 2012; 147(2-3):153-60. PubMed ID: 22633646
[TBL] [Abstract][Full Text] [Related]
22. Molecular analysis of p53, MDM2, and H-ras genes in osteosarcoma and malignant fibrous histiocytoma of bone in patients older than 40 years.
Kawaguchi K; Oda Y; Sakamoto A; Saito T; Tamiya S; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2002 Aug; 15(8):878-88. PubMed ID: 12181274
[TBL] [Abstract][Full Text] [Related]
23. Characterization of canine osteosarcoma by array comparative genomic hybridization and RT-qPCR: signatures of genomic imbalance in canine osteosarcoma parallel the human counterpart.
Angstadt AY; Motsinger-Reif A; Thomas R; Kisseberth WC; Guillermo Couto C; Duval DL; Nielsen DM; Modiano JF; Breen M
Genes Chromosomes Cancer; 2011 Nov; 50(11):859-74. PubMed ID: 21837709
[TBL] [Abstract][Full Text] [Related]
24. Possible prognostic role of IL-17R in osteosarcoma.
Honorati MC; Cattini L; Facchini A
J Cancer Res Clin Oncol; 2007 Dec; 133(12):1017-21. PubMed ID: 17690908
[TBL] [Abstract][Full Text] [Related]
25. Expression of epidermal growth factor receptor in canine osteosarcoma: association with clinicopathological parameters and prognosis.
Selvarajah GT; Verheije MH; Kik M; Slob A; Rottier PJ; Mol JA; Kirpensteijn J
Vet J; 2012 Aug; 193(2):412-9. PubMed ID: 22436430
[TBL] [Abstract][Full Text] [Related]
26. Animal models of osteosarcoma.
Fan TM
Expert Rev Anticancer Ther; 2010 Aug; 10(8):1327-38. PubMed ID: 20735317
[TBL] [Abstract][Full Text] [Related]
27. Wnt/β-Catenin Signaling Activates Expression of the Bone-Related Transcription Factor RUNX2 in Select Human Osteosarcoma Cell Types.
Vega OA; Lucero CMJ; Araya HF; Jerez S; Tapia JC; Antonelli M; Salazar-Onfray F; Las Heras F; Thaler R; Riester SM; Stein GS; van Wijnen AJ; Galindo MA
J Cell Biochem; 2017 Nov; 118(11):3662-3674. PubMed ID: 28370561
[TBL] [Abstract][Full Text] [Related]
28. Parathyroid hormone receptor 1 (PTHR1) is a prognostic indicator in canine osteosarcoma.
Al-Khan AA; Nimmo JS; Tayebi M; Ryan SD; Simcock JO; Tarzi R; Kuntz CA; Saad ES; Day MJ; Richardson SJ; Danks JA
Sci Rep; 2020 Jan; 10(1):1564. PubMed ID: 32005896
[TBL] [Abstract][Full Text] [Related]
29. Use of alkaline phosphatase staining to differentiate canine osteosarcoma from other vimentin-positive tumors.
Barger A; Graca R; Bailey K; Messick J; de Lorimier LP; Fan T; Hoffmann W
Vet Pathol; 2005 Mar; 42(2):161-5. PubMed ID: 15753469
[TBL] [Abstract][Full Text] [Related]
30. Glucose transporter 1 expression in canine osteosarcoma.
Petty JC; Lana SE; Thamm DH; Charles JB; Bachand AM; Bush JM; Ehrhart EJ
Vet Comp Oncol; 2008 Jun; 6(2):133-40. PubMed ID: 19178673
[TBL] [Abstract][Full Text] [Related]
31. Expression of different phenotypes in cell lines from canine mammary spindle-cell tumours and osteosarcomas indicating a pluripotent mammary stem cell origin.
Hellmén E; Moller M; Blankenstein MA; Andersson L; Westermark B
Breast Cancer Res Treat; 2000 Jun; 61(3):197-210. PubMed ID: 10965996
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathologic correlation of vitamin D receptor expression with retinoid X receptor and MIB-1 expression in primary and metastatic osteosarcoma.
Gallagher R; Keighley J; Tancabelic J; Garimella R; Pinson D; Templeton K; Tawfik O
Ann Diagn Pathol; 2012 Oct; 16(5):323-9. PubMed ID: 22542077
[TBL] [Abstract][Full Text] [Related]
33. Proteomics of osteosarcoma.
Bernardini G; Laschi M; Geminiani M; Santucci A
Expert Rev Proteomics; 2014 Jun; 11(3):331-43. PubMed ID: 24654989
[TBL] [Abstract][Full Text] [Related]
34. CXCR7-mediated progression of osteosarcoma in the lungs.
Goguet-Surmenian E; Richard-Fiardo P; Guillemot E; Benchetrit M; Gomez-Brouchet A; Buzzo P; Karimdjee-Soilihi B; Alemanno P; Michiels JF; Schmid-Alliana A; Schmid-Antomarchi H
Br J Cancer; 2013 Sep; 109(6):1579-85. PubMed ID: 24002596
[TBL] [Abstract][Full Text] [Related]
35. Multipotential osteosarcoma with various mesenchymal differentiations in a young dog.
Hoenerhoff MJ; Kiupel M; Rosenstein D; Pool RR
Vet Pathol; 2004 May; 41(3):264-8. PubMed ID: 15133175
[TBL] [Abstract][Full Text] [Related]
36. Effects of transplantation sites on tumour growth, pulmonary metastasis and ezrin expression of canine osteosarcoma cell lines in nude mice.
Jaroensong T; Endo Y; Lee SJ; Kamida A; Mochizuki M; Nishimura R; Sasaki N; Nakagawa T
Vet Comp Oncol; 2012 Dec; 10(4):274-82. PubMed ID: 22236104
[TBL] [Abstract][Full Text] [Related]
37. Intra- and interspecies gene expression models for predicting drug response in canine osteosarcoma.
Fowles JS; Brown KC; Hess AM; Duval DL; Gustafson DL
BMC Bioinformatics; 2016 Feb; 17():93. PubMed ID: 26892349
[TBL] [Abstract][Full Text] [Related]
38. Ascorbic acid induces either differentiation or apoptosis in MG-63 osteosarcoma lineage.
Valenti MT; Zanatta M; Donatelli L; Viviano G; Cavallini C; Scupoli MT; Dalle Carbonare L
Anticancer Res; 2014 Apr; 34(4):1617-27. PubMed ID: 24692690
[TBL] [Abstract][Full Text] [Related]
39. Secreted Frizzled-Related Protein 2 (sFRP2) promotes osteosarcoma invasion and metastatic potential.
Techavichit P; Gao Y; Kurenbekova L; Shuck R; Donehower LA; Yustein JT
BMC Cancer; 2016 Nov; 16(1):869. PubMed ID: 27821163
[TBL] [Abstract][Full Text] [Related]
40. Constitutive expression of non-bone/liver/kidney alkaline phosphatase in human osteosarcoma cell lines.
Ali NN; Rowe J; Teich NM
J Bone Miner Res; 1996 Apr; 11(4):512-20. PubMed ID: 8992882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
